IL30440A - Pharmaceutical preparation for oral administration comprising an active drug and a resin - Google Patents

Pharmaceutical preparation for oral administration comprising an active drug and a resin

Info

Publication number
IL30440A
IL30440A IL30440A IL3044068A IL30440A IL 30440 A IL30440 A IL 30440A IL 30440 A IL30440 A IL 30440A IL 3044068 A IL3044068 A IL 3044068A IL 30440 A IL30440 A IL 30440A
Authority
IL
Israel
Prior art keywords
drug
resin
dosage form
particles
tablet
Prior art date
Application number
IL30440A
Other languages
English (en)
Other versions
IL30440A0 (en
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL30440A0 publication Critical patent/IL30440A0/xx
Publication of IL30440A publication Critical patent/IL30440A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL30440A 1967-08-18 1968-07-26 Pharmaceutical preparation for oral administration comprising an active drug and a resin IL30440A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66160067A 1967-08-18 1967-08-18

Publications (2)

Publication Number Publication Date
IL30440A0 IL30440A0 (en) 1968-09-26
IL30440A true IL30440A (en) 1971-11-29

Family

ID=24654299

Family Applications (1)

Application Number Title Priority Date Filing Date
IL30440A IL30440A (en) 1967-08-18 1968-07-26 Pharmaceutical preparation for oral administration comprising an active drug and a resin

Country Status (7)

Country Link
BR (1) BR6801380D0 (fr)
DE (1) DE1792283A1 (fr)
FR (2) FR1591602A (fr)
GB (1) GB1219026A (fr)
IL (1) IL30440A (fr)
OA (1) OA02878A (fr)
PH (1) PH10958A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
FR2532177A1 (fr) * 1982-08-30 1984-03-02 Being Well Products Inc Complement nutritionnel a zones de liberation determinees et son procede de fabrication
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes

Also Published As

Publication number Publication date
BR6801380D0 (pt) 1973-02-08
PH10958A (en) 1977-10-13
FR7750M (fr) 1970-03-16
GB1219026A (en) 1971-01-13
DE1792283A1 (de) 1971-11-18
IL30440A0 (en) 1968-09-26
OA02878A (fr) 1970-12-15
FR1591602A (fr) 1970-05-04

Similar Documents

Publication Publication Date Title
DK200300005U3 (da) Farmaceutiske pellets indeholdende tamsulosin
RU2201217C2 (ru) Таблетка с энтеросолюбильным покрытием и способ приготовления
JP2773959B2 (ja) 大腸内放出性固形製剤
RU2095054C1 (ru) Твердая лекарственная форма для орального введения
US20240016753A1 (en) Pharmaceutical compositions
BG63708B1 (bg) Лекарствени форми на трамадол
AU6279800A (en) Delayed-action form of administration containing tramadol saccharinate
DK165670B (da) Laegemidler indeholdende 9-desoxo-11-desoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)oxy)-(9s)-erythromycin samt fremgangsmaade til fremstilling af saadanne laegemidler
JPH09500617A (ja) 腸管の異常ｐＨ値の調整及び腸疾患の処置のために使用する組成物
US20190167612A1 (en) Pharmaceutical formulation for oral administration with controlled dissolution rate comprising sustained-release pellets containing tamsulosin hydrochloride
RU2181043C2 (ru) Фармацевтическая композиция для орального введения с модифицированным высвобождением, содержащая 5-аск, и способ лечения кишечных заболеваний
US3784683A (en) Tablet preparation
JPH0354926B2 (fr)
CN108175849B (zh) 聚普瑞锌口服制剂及在制备溃疡性结肠炎药物中的应用
US5234691A (en) Sustained-release prepararation of basic medical agent hydrochloride
US4863741A (en) Tablet composition for drug combinations
IL30440A (en) Pharmaceutical preparation for oral administration comprising an active drug and a resin
CH629960A5 (fr) Composition pharmaceutique.
EP0196002B1 (fr) Comprimés contenant une combinaison de médicaments
RU2790691C1 (ru) Способ получения фармацевтической композиции, содержащей нестероидный противовоспалительный препарат, ингибитор протонной помпы и антацид, фармацевтическая композиция, содержащая нестероидный противовоспалительный препарат, ингибитор протонной помпы и антацид, применение фармацевтической композиции
AU2018269557B2 (en) Formulations of homotaurines and salts thereof
Gopaiah et al. FORMULATION & EVALUATION OMEPRAZOLE DELAYED RELEASE TABLETS
Anitha Formulation and Characterization of Mesalamine Pellets
WO2005120467A2 (fr) Forme posologique contenant l'agent actif cholylsarcosine
EA043575B1 (ru) Фармацевтическая композиция для перорального приема с контролируемой скоростью растворения, содержащая пеллеты с замедленным высвобождением, содержащие тамсулозина гидрохлорид